UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Quality of life research, ISSN 0962-9343, 10/2013, Volume 22, Issue 8, pp. 1889 - 1905
Recommendations | Literature reviews | Construct validity | Health outcomes | Health care outcome assessment | Language translation | Interpretability | Content validity | Quality of life | Empirical evidence | Public Health | Comparative effectiveness | Questionnaire | Medicine & Public Health | Patient-centered outcomes research | Quality of Life Research | Psychometrics | Patient-reported outcomes | Sociology, general | Health Care Sciences & Services | Public, Environmental & Occupational Health | Health Policy & Services | Life Sciences & Biomedicine | Science & Technology | Outcome Assessment (Health Care) - methods | Guidelines as Topic | Reproducibility of Results | Comparative Effectiveness Research - methods | Humans | Patient Outcome Assessment | Comparative Effectiveness Research - standards | Outcome Assessment (Health Care) - standards | Patient Satisfaction | Self Report - standards | Patient-Centered Care - standards | Quality of Life | Research Design - standards | Surveys and Questionnaires | Medicine, Experimental | Medical research | Quality standards | Questionnaires | Attitudes | Quantitative psychology | Patients | Clinical outcomes | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1517 - 1526
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypercholesterolemia - immunology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Injections, Subcutaneous - adverse effects | Proprotein Convertase 9 - immunology | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Anticholesteremic Agents - immunology | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Lipids - blood | Proprotein Convertase 9 - blood | Antibodies - blood | Cholesterol, LDL - blood | Female | Antibodies, Monoclonal, Humanized - immunology | Complications and side effects | Treatment outcome | Immune response | Patient outcomes | Analysis | Dosage and administration | Antilipemic agents | Lipoproteins (low density) | Hyperlipidemia | Clinical trials | Lipids | Subtilisin | Patients | Low density lipoprotein | Cholesterol | Studies | Apolipoprotein B | Kexin | Monoclonal antibodies | Statins | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2010, Volume 28, Issue 16, pp. 2784 - 2795
Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Immunohistochemistry | Predictive Value of Tests | Receptors, Estrogen - metabolism | Receptors, Estrogen - genetics | United States | Humans | Receptors, Progesterone - genetics | Evidence-Based Medicine | Receptors, Progesterone - metabolism | Breast Neoplasms - genetics | Societies, Medical | Breast Neoplasms - pathology | Sensitivity and Specificity | Biomarkers, Tumor - metabolism | Medical Oncology - standards | Female | Biomarkers, Tumor - genetics | Practice Guidelines as Topic | Index Medicus | Bc2 | ASCO Special | To14 | Epid1 | Gdln1 | Bc7
Journal Article
Archives of pathology & laboratory medicine (1976), ISSN 0003-9985, 2010, Volume 134, Issue 7, pp. e48 - 72
Pathology | Life Sciences & Biomedicine | Medical Laboratory Technology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Reproducibility of Results | Biomarkers, Tumor - analysis | Neoplasm Invasiveness | Humans | Neoplasm Recurrence, Local | False Negative Reactions | Receptors, Estrogen - analysis | False Positive Reactions | Breast Neoplasms - drug therapy | Immunohistochemistry - standards | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Algorithms | Breast Neoplasms - pathology | Treatment Failure | Female | Care and treatment | Estrogen | Phenols | Breast cancer | Progesterone | Cancer
Journal Article
BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, ISSN 1173-8804, 10/2019, Volume 33, Issue 5, pp. 571 - 579
Antibodies | Pharmacotherapy | Cancer Research | Molecular Medicine | Biomedicine | Pharmacology & Pharmacy | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Cross Reactions | Humans | Hyperlipidemias - drug therapy | Antibodies, Monoclonal, Humanized - immunology | Proprotein Convertase 9 - immunology | Hypercholesterolemia - drug therapy | Antibodies, Monoclonal - immunology | Randomized Controlled Trials as Topic | Immunoassay | Kexin | Immunogenicity | Cross-reactivity | Monoclonal antibodies | Clinical trials | Cardiovascular disease | Lipids | Subtilisin | FDA approval | Mutation
Journal Article
Archives of pathology & laboratory medicine (1976), ISSN 0003-9985, 2010, Volume 134, Issue 6, pp. 907 - 922
Pathology | Life Sciences & Biomedicine | Medical Laboratory Technology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Predictive Value of Tests | Guidelines as Topic | Receptors, Estrogen - metabolism | United States | Humans | Health Planning Guidelines | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Immunohistochemistry - methods | Algorithms | Societies, Medical | Biomarkers, Tumor - metabolism | Female | Breast Neoplasms - diagnosis | Immunohistochemistry | Hormone receptors | Care and treatment | Usage | Physiological aspects | Practice guidelines (Medicine) | Development and progression | Breast cancer | Diagnosis | Research
Journal Article
The American heart journal, ISSN 0002-8703, 08/2016, Volume 178, pp. 135 - 144
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Hypercholesterolemia - blood | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Hyperlipoproteinemia Type II - blood | Humans | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Hyperlipoproteinemia Type II - drug therapy | Drug Therapy, Combination | Lipoproteins, LDL - blood | Blood circulation disorders | Medical research | Patient outcomes | Low density lipoproteins | Anticholesteremic agents | Monoclonal antibodies | Medicine, Experimental | Studies | Lipids | Pharmaceutical industry | Low density lipoprotein | Statins | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 11/2012, Volume 189, Issue 10, pp. 5029 - 5036
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 11/2012, Volume 189, Issue 10, pp. 5029 - 5036
Immunohistochemistry | T-Lymphocyte Subsets - immunology | CD8-Positive T-Lymphocytes - pathology | Breast Neoplasms - immunology | Humans | Middle Aged | Receptors, Antigen, T-Cell, gamma-delta - immunology | Survival Rate | CD4-Positive T-Lymphocytes - pathology | Breast Neoplasms - therapy | CD4-Positive T-Lymphocytes - immunology | Cell Movement - immunology | Disease-Free Survival | T-Lymphocyte Subsets - pathology | Breast Neoplasms - pathology | Immunotherapy | Aged, 80 and over | Biomarkers | Adult | Breast Neoplasms - mortality | Female | Aged | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Index Medicus | Abridged Index Medicus | Clinical outcome | γδ T Lymphocytes | Tumor immunity | Breast tumor microenvironment | Regulatory T cells
Journal Article